DMD Digital Health Connections Group Inc
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in myeloi… Read more
DMD Digital Health Connections Group Inc - Asset Resilience Ratio
DMD Digital Health Connections Group Inc (APTOF) has an Asset Resilience Ratio of 15.49% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2023)
This chart shows how DMD Digital Health Connections Group Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down DMD Digital Health Connections Group Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.98 Million | 15.49% |
| Total Liquid Assets | $1.98 Million | 15.49% |
Asset Resilience Insights
- Good Liquidity Position: DMD Digital Health Connections Group Inc maintains a healthy 15.49% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
DMD Digital Health Connections Group Inc Industry Peers by Asset Resilience Ratio
Compare DMD Digital Health Connections Group Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for DMD Digital Health Connections Group Inc (2014–2023)
The table below shows the annual Asset Resilience Ratio data for DMD Digital Health Connections Group Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.00% | $0.00 | $12.99 Million | -- |
| 2022-12-31 | 19.58% | $9.99 Million | $51.03 Million | -28.91pp |
| 2021-12-31 | 48.49% | $40.01 Million | $82.53 Million | +23.99pp |
| 2017-12-31 | 24.49% | $8.60 Million | $35.11 Million | +6.96pp |
| 2016-12-31 | 17.53% | $5.76 Million | $32.87 Million | +12.17pp |
| 2015-12-31 | 5.36% | $1.42 Million | $26.56 Million | +5.20pp |
| 2014-12-31 | 0.16% | $28.00K | $17.92 Million | -- |